Subclass analysis of malignant,iInflammatory and degenerative pathologies based on multiple timepoint FAPI-PET acquisitions using FAPI-02, FAPI-46 and FAPI-74

Purpose: FAPI-PET is a promising imaging technique for various malignant as well as non-malignant pathologies. In a recent retrospective analysis, we evaluated the diagnostic value of repetitive early FAPI-PET-imaging with FAPI-02, FAPI-46 and FAPI-74 for malignant, inflammatory/reactive and degener...

Full description

Saved in:
Bibliographic Details
Main Authors: Glatting, Frederik M. (Author) , Hoppner, Jorge (Author) , Kauczor, Hans-Ulrich (Author) , Huber, Peter E. (Author) , Kratochwil, Clemens (Author) , Giesel, Frederik L. (Author) , Haberkorn, Uwe (Author) , Röhrich, Manuel (Author)
Format: Article (Journal)
Language:English
Published: 28 October 2022
In: Cancers
Year: 2022, Volume: 14, Issue: 21, Pages: 1-20
ISSN:2072-6694
DOI:10.3390/cancers14215301
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers14215301
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/14/21/5301
Get full text
Author Notes:Frederik M. Glatting, Jorge Hoppner, Hans-Ulrich Kauczor, Peter E. Huber, Clemens Kratochwil, Frederik L. Giesel, Uwe Haberkorn and Manuel Röhrich

MARC

LEADER 00000caa a2200000 c 4500
001 1831768615
003 DE-627
005 20230707001519.0
007 cr uuu---uuuuu
008 230123s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers14215301  |2 doi 
035 |a (DE-627)1831768615 
035 |a (DE-599)KXP1831768615 
035 |a (OCoLC)1389535979 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Glatting, Frederik M.  |d 1995-  |e VerfasserIn  |0 (DE-588)1256743860  |0 (DE-627)1800791356  |4 aut 
245 1 0 |a Subclass analysis of malignant,iInflammatory and degenerative pathologies based on multiple timepoint FAPI-PET acquisitions using FAPI-02, FAPI-46 and FAPI-74  |c Frederik M. Glatting, Jorge Hoppner, Hans-Ulrich Kauczor, Peter E. Huber, Clemens Kratochwil, Frederik L. Giesel, Uwe Haberkorn and Manuel Röhrich 
264 1 |c 28 October 2022 
300 |a 20 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.01.2023 
520 |a Purpose: FAPI-PET is a promising imaging technique for various malignant as well as non-malignant pathologies. In a recent retrospective analysis, we evaluated the diagnostic value of repetitive early FAPI-PET-imaging with FAPI-02, FAPI-46 and FAPI-74 for malignant, inflammatory/reactive and degenerative pathologies. Here, we apply a subgroup analysis to that dataset and describe the tracer-wise uptake kinetic behavior of multiple types of FAPI-positive lesions, which are encountered frequently during clinical routine. Methods: A total of 24 cancer patients underwent whole-body FAPI-PET scans, and images were acquired at 10, 22, 34, 46 and 58 min after the administration of 150-250 MBq of 68Ga-FAPI tracer molecules (eight patients each regarding FAPI-02, FAPI-46 and FAPI-74). Standardized uptake values (SUVmax and SUVmean) of healthy tissues, cancer manifestations and non-malignant lesions were measured and target-to-background ratios (TBR) versus blood and fat were calculated for all acquisition timepoints. Results: Differential uptake behavior over time was observed in several subclasses of malignant lesions, inflammatory/reactive lesions and degenerative lesions. These differences over time were particularly manifested in the direct comparison between the uptakes associated with pancreatic carcinoma (stable or increasing over time) and inflammatory lesions of the pancreas (markedly decreasing over time). Furthermore, marked differences were found between the three tracer variants regarding their time-dependent uptake and TBRs within different subclasses of malignant, inflammatory/reactive and degenerative pathologies. Conclusion: Multiple timepoint FAPI-PET/CT is a promising innovative imaging technique that provides additional imaging information compared to single timepoint imaging. Differences in the kinetic behavior of malignant and benign pathologies can facilitate the interpretation of FAPI-positive lesions. 
650 4 |a cancer 
650 4 |a degeneration 
650 4 |a FAPI 
650 4 |a fibroblast activation protein 
650 4 |a inflammation 
650 4 |a pancreatic carcinoma 
650 4 |a pancreatitis 
650 4 |a PET 
700 1 |a Hoppner, Jorge  |d 1986-  |e VerfasserIn  |0 (DE-588)1156687160  |0 (DE-627)101952328X  |0 (DE-576)502374209  |4 aut 
700 1 |a Kauczor, Hans-Ulrich  |d 1962-  |e VerfasserIn  |0 (DE-588)139267123  |0 (DE-627)70327113X  |0 (DE-576)310955327  |4 aut 
700 1 |a Huber, Peter E.  |d 1965-  |e VerfasserIn  |0 (DE-588)1074678869  |0 (DE-627)832350109  |0 (DE-576)442767803  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Röhrich, Manuel  |d 1983-  |e VerfasserIn  |0 (DE-588)1137027177  |0 (DE-627)893969826  |0 (DE-576)491054769  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 14(2022), 21, Artikel-ID 5301, Seite 1-20  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Subclass analysis of malignant,iInflammatory and degenerative pathologies based on multiple timepoint FAPI-PET acquisitions using FAPI-02, FAPI-46 and FAPI-74 
773 1 8 |g volume:14  |g year:2022  |g number:21  |g elocationid:5301  |g pages:1-20  |g extent:20  |a Subclass analysis of malignant,iInflammatory and degenerative pathologies based on multiple timepoint FAPI-PET acquisitions using FAPI-02, FAPI-46 and FAPI-74 
856 4 0 |u https://doi.org/10.3390/cancers14215301  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/14/21/5301  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230123 
993 |a Article 
994 |a 2022 
998 |g 1137027177  |a Röhrich, Manuel  |m 1137027177:Röhrich, Manuel  |d 910000  |d 911400  |e 910000PR1137027177  |e 911400PR1137027177  |k 0/910000/  |k 1/910000/911400/  |p 8  |y j 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |d 50000  |e 910000PG129031240  |e 911400PG129031240  |e 50000PG129031240  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 6 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 1074678869  |a Huber, Peter E.  |m 1074678869:Huber, Peter E.  |d 910000  |d 911400  |d 50000  |e 910000PH1074678869  |e 911400PH1074678869  |e 50000PH1074678869  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 4 
998 |g 139267123  |a Kauczor, Hans-Ulrich  |m 139267123:Kauczor, Hans-Ulrich  |d 910000  |d 911400  |d 50000  |e 910000PK139267123  |e 911400PK139267123  |e 50000PK139267123  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 3 
998 |g 1156687160  |a Hoppner, Jorge  |m 1156687160:Hoppner, Jorge  |d 910000  |d 911400  |e 910000PH1156687160  |e 911400PH1156687160  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1256743860  |a Glatting, Frederik M.  |m 1256743860:Glatting, Frederik M.  |d 60000  |e 60000PG1256743860  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1831768615  |e 4250614468 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"20 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basel","publisher":"MDPI"}],"id":{"zdb":["2527080-1"],"issn":["2072-6694"],"eki":["614095670"]},"disp":"Subclass analysis of malignant,iInflammatory and degenerative pathologies based on multiple timepoint FAPI-PET acquisitions using FAPI-02, FAPI-46 and FAPI-74Cancers","note":["Gesehen am 27.05.2020"],"recId":"614095670","part":{"text":"14(2022), 21, Artikel-ID 5301, Seite 1-20","pages":"1-20","year":"2022","issue":"21","volume":"14","extent":"20"},"title":[{"title_sort":"Cancers","title":"Cancers"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]}}],"name":{"displayForm":["Frederik M. Glatting, Jorge Hoppner, Hans-Ulrich Kauczor, Peter E. Huber, Clemens Kratochwil, Frederik L. Giesel, Uwe Haberkorn and Manuel Röhrich"]},"note":["Gesehen am 23.01.2023"],"id":{"eki":["1831768615"],"doi":["10.3390/cancers14215301"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"28 October 2022"}],"person":[{"roleDisplay":"VerfasserIn","family":"Glatting","given":"Frederik M.","role":"aut","display":"Glatting, Frederik M."},{"given":"Jorge","role":"aut","display":"Hoppner, Jorge","roleDisplay":"VerfasserIn","family":"Hoppner"},{"role":"aut","display":"Kauczor, Hans-Ulrich","given":"Hans-Ulrich","family":"Kauczor","roleDisplay":"VerfasserIn"},{"given":"Peter E.","role":"aut","display":"Huber, Peter E.","family":"Huber","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Kratochwil, Clemens","given":"Clemens","family":"Kratochwil","roleDisplay":"VerfasserIn"},{"display":"Giesel, Frederik L.","role":"aut","given":"Frederik L.","roleDisplay":"VerfasserIn","family":"Giesel"},{"role":"aut","display":"Haberkorn, Uwe","given":"Uwe","family":"Haberkorn","roleDisplay":"VerfasserIn"},{"family":"Röhrich","roleDisplay":"VerfasserIn","given":"Manuel","display":"Röhrich, Manuel","role":"aut"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Subclass analysis of malignant,iInflammatory and degenerative pathologies based on multiple timepoint FAPI-PET acquisitions using FAPI-02, FAPI-46 and FAPI-74","title_sort":"Subclass analysis of malignant,iInflammatory and degenerative pathologies based on multiple timepoint FAPI-PET acquisitions using FAPI-02, FAPI-46 and FAPI-74"}],"recId":"1831768615"} 
SRT |a GLATTINGFRSUBCLASSAN2820